You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Outcomes, loss to follow-up, and mortality rates of Standardized Pediatric Expedited Encounters for ART Drugs Initiative (SPEEDI) patients (n = 1164)

From: The Standardized Pediatric Expedited Encounters for ART Drugs Initiative (SPEEDI): description and evaluation of an innovative pediatric, adolescent, and young adult antiretroviral service delivery model in Tanzania

Indicator SPEEDI Patients (n = 1164)
% Good outcomes (n)      -Active in care (n)      -Transferred out (n) 98.3% (1144/1164)      −91.3% (1063/1164)      −7.0% (81/1164)
% Poor outcomes (n)      -Died (n)      -Lost-to-follow up (n) 1.2% (14/1164)      −1.1% (13/1164)      −0.6% (7/1164)
Mortality rate 0.61 deaths per 100 patient-years